Literature DB >> 19943736

The differential effects of pathway- versus target-derived glial cell line-derived neurotrophic factor on peripheral nerve regeneration.

Christina K Magill1, Amy M Moore, Ying Yan, Alice Y Tong, Matthew R MacEwan, Andrew Yee, Ayato Hayashi, Daniel A Hunter, Wilson Z Ray, Philip J Johnson, Alexander Parsadanian, Terence M Myckatyn, Susan E Mackinnon.   

Abstract

OBJECT: Glial cell line-derived neurotrophic factor (GDNF) has potent survival effects on central and peripheral nerve populations. The authors examined the differential effects of GDNF following either a sciatic nerve crush injury in mice that overexpressed GDNF in the central or peripheral nervous systems (glial fibrillary acidic protein [GFAP]-GDNF) or in the muscle target (Myo-GDNF).
METHODS: Adult mice (GFAP-GDNF, Myo-GDNF, or wild-type [WT] animals) underwent sciatic nerve crush and were evaluated using histomorphometry and muscle force and power testing. Uninjured WT animals served as controls.
RESULTS: In the sciatic nerve crush, the Myo-GDNF mice demonstrated a higher number of nerve fibers, fiber density, and nerve percentage (p < 0.05) at 2 weeks. The early regenerative response did not result in superlative functional recovery. At 3 weeks, GFAP-GDNF animals exhibit fewer nerve fibers, decreased fiber width, and decreased nerve percentage compared with WT and Myo-GDNF mice (p < 0.05). By 6 weeks, there were no significant differences between groups.
CONCLUSIONS: Peripheral delivery of GDNF resulted in earlier regeneration following sciatic nerve crush injuries than that with central GDNF delivery. Treatment with neurotrophic factors such as GDNF may offer new possibilities for the treatment of peripheral nerve injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19943736      PMCID: PMC2891941          DOI: 10.3171/2009.10.JNS091092

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  55 in total

1.  Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS.

Authors:  M Trupp; N Belluardo; H Funakoshi; C F Ibáñez
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

2.  GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo.

Authors:  E Arenas; M Trupp; P Akerud; C F Ibáñez
Journal:  Neuron       Date:  1995-12       Impact factor: 17.173

3.  Nerve crush injuries--a model for axonotmesis.

Authors:  P M Bridge; D J Ball; S E Mackinnon; Y Nakao; K Brandt; D A Hunter; C Hertl
Journal:  Exp Neurol       Date:  1994-06       Impact factor: 5.330

4.  Myogenin and acetylcholine receptor alpha gene promoters mediate transcriptional regulation in response to motor innervation.

Authors:  J P Merlie; J Mudd; T C Cheng; E N Olson
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

5.  Differential regulation of mRNAs for GDNF and its receptors Ret and GDNFR alpha after sciatic nerve lesion in the mouse.

Authors:  P Naveilhan; W M ElShamy; P Ernfors
Journal:  Eur J Neurosci       Date:  1997-07       Impact factor: 3.386

6.  GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle.

Authors:  C E Henderson; H S Phillips; R A Pollock; A M Davies; C Lemeulle; M Armanini; L Simmons; B Moffet; R A Vandlen; L Simpson LC corrected to Simmons; V E Koliatsos; A Rosenthal
Journal:  Science       Date:  1994-11-11       Impact factor: 47.728

7.  Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF.

Authors:  R W Oppenheim; L J Houenou; J E Johnson; L F Lin; L Li; A C Lo; A L Newsome; D M Prevette; S Wang
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

8.  In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons.

Authors:  Q Yan; C Matheson; O T Lopez
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

Review 9.  Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors.

Authors:  N J Laping; B Teter; N R Nichols; I Rozovsky; C E Finch
Journal:  Brain Pathol       Date:  1994-07       Impact factor: 6.508

10.  Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro.

Authors:  Srinivas Madduri; Michaël Papaloïzos; Bruno Gander
Journal:  Neurosci Res       Date:  2009-06-11       Impact factor: 3.304

View more
  8 in total

1.  Lentiviral vector-mediated gradients of GDNF in the injured peripheral nerve: effects on nerve coil formation, Schwann cell maturation and myelination.

Authors:  Ruben Eggers; Fred de Winter; Stefan A Hoyng; Kasper C D Roet; Erich M Ehlert; Martijn J A Malessy; Joost Verhaagen; Martijn R Tannemaat
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

2.  Treating small fiber neuropathy by topical application of a small molecule modulator of ligand-induced GFRα/RET receptor signaling.

Authors:  Kristian L Hedstrom; Joshua C Murtie; Kathryn Albers; Nigel A Calcutt; Gabriel Corfas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-21       Impact factor: 11.205

3.  Glial-derived growth factor and pleiotrophin synergistically promote axonal regeneration in critical nerve injuries.

Authors:  Nesreen Zoghoul Alsmadi; Geetanjali S Bendale; Aswini Kanneganti; Tarik Shihabeddin; An H Nguyen; Elijah Hor; Swarup Dash; Benjamin Johnston; Rafael Granja-Vazquez; Mario I Romero-Ortega
Journal:  Acta Biomater       Date:  2018-07-29       Impact factor: 8.947

4.  Viral transduction of primary Schwann cells using a Cre-lox system to regulate GDNF expression.

Authors:  Yuewei Wu-Fienberg; Amy M Moore; Laura M Marquardt; Piyaraj Newton; Philip J Johnson; Susan E Mackinnon; Shelly E Sakiyama-Elbert; Matthew D Wood
Journal:  Biotechnol Bioeng       Date:  2014-04-24       Impact factor: 4.530

5.  Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling.

Authors:  Bogdan Beirowski; Jason Gustin; Sean M Armour; Hiroyasu Yamamoto; Andreu Viader; Brian J North; Shaday Michán; Robert H Baloh; Judy P Golden; Robert E Schmidt; David A Sinclair; Johan Auwerx; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

6.  A customizable microfluidic platform for medium-throughput modeling of neuromuscular circuits.

Authors:  Jessica Bellmann; Ruchi Y Goswami; Salvatore Girardo; Nelly Rein; Zohreh Hosseinzadeh; Michael R Hicks; Volker Busskamp; April D Pyle; Carsten Werner; Jared Sterneckert
Journal:  Biomaterials       Date:  2019-10-08       Impact factor: 12.479

7.  Controlled release of nerve growth factor from heparin-conjugated fibrin gel within the nerve growth factor-delivering implant.

Authors:  Jin-Yong Lee; Soung-Min Kim; Myung-Jin Kim; Jong-Ho Lee
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2014-02-25

Review 8.  ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease.

Authors:  Elizabeth B Moloney; Fred de Winter; Joost Verhaagen
Journal:  Front Neurosci       Date:  2014-08-14       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.